Industry Survey: FDA Regs Driving VC Investment Overseas

An estimated 42% of U.S. venture capital firms will reduce their medical device sector investments over the next three years due to a perception that FDA regulations are cost-prohibitive, arbitrary and cumbersome, according to the latest industry survey.